semaglutide $199 6-Month Plan: Just $99/month! GLP-1 - For Weight Loss

Additional indications Knee osteoarthritis, sleep apnea, MASLD, cardiovascular outcomes, and chronic low back pain would follow based on their respective trial timelines This mirrors how Lilly handled tirzepatide: Mounjaro was approved for diabetes first (May 2022), followed by Zepbound for obesity (November 2023)

Hormonal Birth Control Anti-Androgen Therapy Antipsychotic Medications Diagnosing Drug-Induced Dry Eye If you think you have dry eye, its best to see an ophthalmologist or eye doctor

Remember how we said that Wegovy and Ozempic are largely the same

Tirzepatide Dual GIP/GLP-1 agonist for enhanced effects